Assessment of effectiveness of treatment in pregnant women with pyelonephritis


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

Relevance of the issue. High prevalence of pyelonephritis (up to 10%) in pregnant women is an acute problem. The issues of pathogenesis, early diagnosis, prevention of recurrence of the disease remain unsolved. Due to anatomical and physiological changes in the body during pregnancy, urinary tract infection becomes complicated, and effective therapy is especially important. Aim. Optimization of treatment and prevention of recurrent pyelonephritis in pregnant women. Materials and methods. 60 pregnant women with gestational pyelonephritis and acute chronic pyelonephritis, who received standard antibiotic therapy. Additionally, the patients in the main group (n = 30) were prescribed systemic enzyme therapy (Wobenzym). Before and after therapy, all patients underwent Doppler ultrasound examination to determine the blood flow rates in renal and interlobar arteries. Results. The women in both groups were comparable in terms of age, gestation period and clinical characteristics of the disease. Before treatment blood flow indices in renal and interlobar arteries were high in both groups. However, in the group of women, who received Wobenzym, Doppler iindices for blood flow were of normal range in the renal artery (p=0.004) and in the interlobar artery (p=0.001), while standard therapy did not show statistically significant differences. Adding Wobenzym to therapy increased the chances for normalization of the blood flow in renal artery by 7 times (95% CI: 1,38-35,5; p=0,01). Systemic enzyme therapy reduced the recurrence of the disease by 4,5 times (95% CI: 1,09-18,5) compared to the comparison group (p=0.0287). Conclusion. Thus, the use of Wobenzym in complex therapy versus standard therapy had a beneficial effect on statistically significant improvement in renal blood flow and a decrease in the frequency of recurrence of the disease.

Texto integral

Acesso é fechado

Sobre autores

Alexandra Khudovekova

D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology

Email: alexandra-ruskhud@yandex.ru
graduate student

Elena Mozgovaya

D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology

Email: elmozg@mail.ru
MD, PhD, DSci (Medicine), the Head

Stanislava Nagorneva

D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology

Email: stanislava_n@bk.ru
physician of ultrasound department

Victoria Prokhorova

D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology

Email: viprokhorova@yandex.ru
the Head of Ultrasound Department

Sergey Selkov

D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology

Email: selkovsa@mail.ru
Dr. Med. Sci., Professor, Head of the Department of Immunology and Intercellular Interactions

Sergey Chepanov

D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology

Email: chepanovsv@gmail.com
PhD, Senior scientist, Proteom Immunoregulation Group, Department of Immunology and Intercellular Interactions

Bibliografia

  1. Горин В.С., Ким В.Л., Серебренникова Е.С. Беременность и хронический пиелонефрит: клинические и иммунологические аспекты (обзор). Российский вестник акушера-гинеколога. 2016; 16(5): 19-28. [Gorin V.S., Kim V.L., Serebrennikova E.S. Pregnancy and chronic pyelonephritis: Clinical and immunological aspects (a review). Russian Bulletin of Obstetrician-Gynecologist. 2016; 16(5): 19-28. (in Russian)]. http://dx.doi.org/10.17116/ rosakush201616519-28
  2. Каптильный В.А. Инфекция мочевыводящих путей во время беременности. Архив акушерства и гинекологии им. В.Ф. Снегирева. 2015; 2(4): 10-9. [Kaptilnyy V.A. Urinary tract infection in pregnancy. Archive of Obstetrics and Gynecology named after V. F. Snegirev. 2015; 2(4): 10-9. (in Russian)].
  3. Боташев М.И., Байрамкулов У.М., Ураскулов А.Б., Семенов А.Р., Коркмазов А.М. Особенности лечения острого пиелонефрита беременных. Дискуссионные статьи. Вестник урологии. 2019; 7(4): 29-34. https://dx.doi.org/10.21886/2308-6424-2019-7-4-29-34.
  4. Михайлова О.И., Арушанова А.Г., Аношин А.С., Кан Н.Е., Тютюнник В.Л. Принципы антибактериальной терапии при инфекции мочевыводящих путей у беременных. Акушерство и гинекология: новости, мнения, обучение. 2016; 2: 12-7. [Mikchailova O.I., Arushanova A.G., Anoshin A.S., Kan N.E., Tyutyunnik V.L. Antibacterial therapy principles of urinary tract infections in pregnant women. Obstetrics and Gynecology: News. Opinions. Training. 2016; 2: 12-7. (in Russian)].
  5. Курбаналиев Х.Р., Чернецова Г.С. Пиелонефрит беременных. Современный взгляд урогинекологов. Вестник Киргизско-Российского славянского университета. 2017; 17(7): 33-6. [Kurbanaliev H.R., Chernetsova G.S. Pyelonefritis pregnant women. The modern view on the problem of urogynecologic (review). Vestnik KRSU. 2017; 17(7): 33-6. (in Russian)].
  6. Будник Т.В. Антибиотикорезистентность в контексте инфекции мочевыводящих путей. Семейная медицина. 2015; 4: 77-84. [Budnik T.V. Antibiotic resistance in the context of urinary tract infection. Family medicine. 2015; 4: 77-84. (in Russian)].
  7. Мальцев С.В., Мансурова Г.Ш. Показатели аутоиммунитета как биомаркеры риска развития и хронизации пиелонефрита. Практическая медицина. 2009; 7: 99-104. [S.V. Maltsev S.V., Mansurova G.Sh. Indicators of autoimmunity as biomarkers of risk of development and chronization of pyelonephritis. Journal of practice medicine. 2009; 7: 99-104. (in Russian)].
  8. Рищук С.В., Кахиани Е.И., Россолько Д.С., Савина Л.В., Душенкова Т.А., Дудниченко Т.А. Урогенитальная эндогенная бактериальная инфекция и системная энзимотерапия. Медицинский совет. 2016; 17: 124-32. [Rischuk S.V., Kakhiani E.I., Rossolko D.S., Savina L.V., Dushenkova T.A., Dudnichenko T.A. Urogenital endogenous bacterial infection and systematic enzymotherapy. Medical Council. 2016; 17: 124-32. (in Russian)].
  9. Tublin M.E., Bude R.O., Platt J.F. The resistive index in renal Doppler sonography: where do we stand? AJR Am. J. Roentgenol. 2003; 180(4): 885-92. http://dx.doi.org/10.2214/ajr.180.4.1800885.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Bionika Media, 2020

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies